The future of HIV treatment promises even better options including long-acting therapies, improved formulations, and potential cure strategies.

Long-Acting Injectable ART:
Monthly or bi-monthly injectable antiretrovirals are in development and some are already approved, reducing the burden of daily pills.

Long-Acting Dolutegravir:
Research is ongoing for long-acting formulations of Dolutegravir that could be administered monthly or less frequently.

Broadly Neutralizing Antibodies:
These antibodies target multiple HIV strains and show promise for both treatment and prevention.

HIV Cure Research:
Scientists are exploring strategies to eliminate HIV from the body, including "shock and kill" approaches and gene therapy.

Improved Formulations:
Development of better-tasting pediatric formulations, smaller pills, and fixed-dose combinations continues.

Prevention Advances:
Long-acting PrEP, vaginal rings, and potential HIV vaccines are in various stages of development.

Personalized Medicine:
Genetic testing and pharmacogenomics may help tailor HIV treatment to individual patients for optimal outcomes.

Global Elimination Goals:
WHO 95-95-95 targets: 95% diagnosed, 95% on treatment, 95% virally suppressed by 2030.